Clinical Trials Browser

Recruiting × Recurrence × tislelizumab × Clear all

NCT06420440 2025-05-01

Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence